SCHEMBL572364

SCHEMBL572364

CC(C)(C)N1CCN(C(=O)[C@H]2CC[C@@H](Nc3cc(Cl)ncc3[N+](=O)[O-])CC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 1/20 0.44
HCAR3 P49019 3/20 0.40
MAPT P10636 4/20 0.38
MAPK1 P28482 2/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK8 P45983 1/20 0.36
POLB P06746 1/20 0.35
CNR1 P21554 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GAA P10253 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MELK Q14680 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572591 0.88 CNR1 (0.42) DCTPP1MAPTMAPK1LMNAHTT
SCHEMBL572590 0.88 CNR1 (0.42) DCTPP1MAPTMAPK1LMNAHTT
SCHEMBL573176 0.83 DCTPP1 (0.40) DCTPP1HCAR3MAPTMAPK1LMNA
SCHEMBL573175 0.83 DCTPP1 (0.40) DCTPP1HCAR3MAPTMAPK1LMNA
SCHEMBL573174 0.83 DCTPP1 (0.40) DCTPP1HCAR3MAPTMAPK1LMNA
SCHEMBL572153 0.81 HCAR3 (0.48) DCTPP1HCAR3MAPTMAPK1HTT
SCHEMBL572154 0.81 HCAR3 (0.48) DCTPP1HCAR3MAPTMAPK1HTT
SCHEMBL572975 0.81 HCAR3 (0.48) DCTPP1HCAR3MAPTMAPK1HTT
SCHEMBL30726366 0.80 MEN1 (0.49) DCTPP1HCAR3MAPTMAPK1LMNA
SCHEMBL15174387 0.80 MEN1 (0.49) DCTPP1HCAR3MAPTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611784-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE Amgen, Inc (US) 2013-07-10 EP disclosed
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 WO disclosed